XML 37 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net income (loss) $ 6,475,000 $ 13,069,000 $ (15,944,000)
Adjustments to reconcile net income or loss to net cash provided by operating activities:      
Depreciation and amortization expense 93,787,000 97,171,000 103,743,000
Amortization of above and below market leases (402,000) (556,000) (1,031,000)
Shares issued as compensation 337,000    
Hedge ineffectiveness     1,878,000
Loss on sale of properties and properties held for sale     18,481,000
Equity in (income) loss of non-consolidated REITs   (6,793,000) 3,604,000
Increase (decrease) in allowance for doubtful accounts and write-off of accounts receivable (71,000) (50,000) 150,000
Changes in operating assets and liabilities:      
Tenant rent receivables 158,000 (765,000) (160,000)
Straight-line rents (8,876,000) 381,000 (1,767,000)
Lease acquisition costs (3,999,000) (1,193,000) (2,052,000)
Prepaid expenses and other assets 2,313,000 (1,940,000) (403,000)
Accounts payable and accrued expenses 3,910,000 (4,077,000) 3,870,000
Accrued compensation 357,000 (598,000) (143,000)
Tenant security deposits 3,027,000 936,000 28,000
Payment of deferred leasing commissions (15,101,000) (15,383,000) (14,309,000)
Net cash provided by operating activities 81,915,000 80,202,000 95,945,000
Cash flows from investing activities:      
Property improvements, fixtures and equipment (70,746,000) (51,057,000) (54,187,000)
Office computers and furniture     (119,000)
Investment in non-consolidated REITs   74,931,000  
Distributions in excess of earnings from non-consolidated REITs   710,000 1,396,000
Investment in related party mortgage loan receivable (2,400,000)    
Repayment of related party mortgage loan receivable 52,060,000 1,060,000 10,060,000
Proceeds received on sales of real estate assets     37,756,000
Proceeds received from liquidating trust 1,470,000    
Net cash provided by (used in) investing activities (19,616,000) 25,644,000 (5,094,000)
Cash flows from financing activities:      
Distributions to stockholders (38,603,000) (49,326,000) (81,496,000)
Borrowings under bank note payable 45,000,000 38,000,000 75,000,000
Repayments of bank note payable (70,000,000) (91,000,000) (277,000,000)
Borrowing of Series A & Series B Senior Notes     200,000,000
Deferred financing costs (83,000) (2,162,000) (6,902,000)
Net cash used in financing activities (63,686,000) (104,488,000) (90,398,000)
Net increase (decrease) in cash, cash equivalents and restricted cash (1,387,000) 1,358,000 453,000
Cash, cash equivalents and restricted cash, beginning of year 11,177,000 9,819,000 9,366,000
Cash, cash equivalents and restricted cash, end of period 9,790,000 11,177,000 9,819,000
Cash paid for:      
Interest 34,470,000 35,885,000 29,969,000
Taxes on income 508,000 485,000 584,000
Non-cash investing and financing activities:      
Accrued costs for purchase of real estate assets $ 11,012,000 $ 7,361,000 $ 5,140,000